Vext Science, Inc.
VEXTF
$0.0943
$0.0022.17%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 36.00M | 34.22M | 33.33M | 34.09M | 34.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.00M | 34.22M | 33.33M | 34.09M | 34.81M |
| Cost of Revenue | 27.01M | 25.50M | 25.77M | 25.42M | 22.77M |
| Gross Profit | 8.99M | 8.72M | 7.56M | 8.67M | 12.04M |
| SG&A Expenses | 11.44M | 16.09M | 15.78M | 13.66M | 13.89M |
| Depreciation & Amortization | 8.74M | 8.58M | 8.16M | 6.95M | 6.04M |
| Other Operating Expenses | 374.00K | -1.00K | -7.00K | -13.00K | -19.00K |
| Total Operating Expenses | 47.55M | 50.16M | 49.70M | 46.02M | 42.68M |
| Operating Income | -11.55M | -15.94M | -16.37M | -11.93M | -7.87M |
| Income Before Tax | -21.12M | -5.99M | -6.15M | -2.24M | 3.36M |
| Income Tax Expenses | 1.31M | 1.60M | 778.70K | -235.20K | -1.04M |
| Earnings from Continuing Operations | -22.44 | -7.59 | -6.93 | -2.01 | 4.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.44M | -7.59M | -6.93M | -2.01M | 4.40M |
| EBIT | -11.55M | -15.94M | -16.37M | -11.93M | -7.87M |
| EBITDA | 2.84M | -1.85M | -3.57M | -949.40K | 1.49M |
| EPS Basic | -0.09 | -0.03 | -0.03 | -0.01 | 0.02 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.05 | -0.05 | -0.03 |
| EPS Diluted | -0.10 | -0.03 | -0.03 | -0.01 | 0.02 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.05 | -0.05 | -0.03 |
| Average Basic Shares Outstanding | 963.58M | 925.27M | 829.48M | 733.76M | 658.14M |
| Average Diluted Shares Outstanding | 966.91M | 929.61M | 830.72M | 735.37M | 659.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |